Most of the 38 million people living with diabetes in the U.S. use daily injections or insulin pumps to keep glucose at safe levels — but new research suggests that a third option could be just as ...

Inhaled insulin Afrezza has launched in India, offering a needle-free option for diabetes management. Designed to overcome needle phobia and insulin inertia, it delivers rapid-acting insulin through ...